Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 15.
doi: 10.1007/s13346-025-01876-y. Online ahead of print.

Synergy of dissolving microneedles and ultrasound to enhance transdermal delivery for rheumatoid arthritis

Affiliations

Synergy of dissolving microneedles and ultrasound to enhance transdermal delivery for rheumatoid arthritis

Wangrui Peng et al. Drug Deliv Transl Res. .

Abstract

Dissolving microneedles (DMNs) are an emerging transdermal drug delivery system that has gained increasing attention as an alternative to traditional oral and injectable methods for treating rheumatoid arthritis (RA). However, these DMNs encounter challenges related to insufficient drug diffusion through passive mechanisms. To address this issue, we developed biocompatible DMNs fabricated from hyaluronic acid (HA) loaded with ultrasound-responsive nanoparticles, aiming at enhancing drug permeation and diffusion through ultrasound (US) assistance. Methotrexate (MTX), a first-line treatment for RA, was encapsulated in poly (lactic-co-glycolic acid) (PLGA)-based nanoparticles containing perfluoro-n-pentane (PFP), referred to as MTX-PFP-NPs. These nanoparticles were then incorporated into DMNs, designated as MTX-PFP-NPs@DMNs. Under the cavitation effect of ultrasound, PFP undergoes a phase transition that facilitates drug release and diffusion. The synergistic effect of the DMNs system and US were demonstrated in both an ex-vivo rat skin model and a collagen-induced arthritis (CIA) mouse model. The MTX-PFP-NPs@DMNs exhibited sufficient mechanical strength to penetrate the stratum corneum and dissolve completely within 20 min, enabling effective drug delivery. The synergistic effect of the DMNs system and US was evidenced by enhanced FITC penetration and diffusion in the ex-vivo rat skin model. Additionally, in vivo studied showed improved therapeutic efficacy in reducing joint swelling, bone erosion, cartilage damage, and pro-inflammatory cytokines level compared to only MTX-PFP-NPs@DMNs. This research underscores the promising integration of DMNs technology and US, offering a high-compliance approach to transdermal drug delivery that could significantly improve treatment outcomes for chronic conditions like RA.

Keywords: Dissolving microneedles; Drug diffusion; Rheumatoid arthritis; Transdermal drug delivery; Ultrasound-responsive.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: All animal experimental procedures were approved by the Ethics Committee on Laboratory Animals of the University of South China. Consent for publication: Not applicable. Competing interests: All authors have agreed with publication of the manuscript.

Similar articles

Cited by

References

    1. Di Matteo A, Bathon JM, Emery P. Rheumatoid arthritis. Lancet. 2023;402(10416):2019–33. https://doi.org/10.1016/s0140-6736(23)01525-8 . - DOI - PubMed
    1. Xu Y, Zhao M, Cao J, Fang T, Zhang J, Zhen Y, et al. Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis. Acta pharmaceutica Sinica B. 2023;13(11):4417–41. https://doi.org/10.1016/j.apsb.2023.05.025 . - DOI - PubMed - PMC
    1. An X, Yang J, Cui X, Zhao J, Jiang C, Tang M, et al. Advances in local drug delivery technologies for improved rheumatoid arthritis therapy. Adv Drug Deliv Rev. 2024;209:115325. https://doi.org/10.1016/j.addr.2024.115325 . - DOI - PubMed
    1. Dogra S, Singh N, Kumar S, Narang T, Handa S. Comparison of overall efficacy and safety of oral versus subcutaneous methotrexate in severe psoriasis. Dermatol Ther. 2022;35(8):e15656. https://doi.org/10.1111/dth.15656 . - DOI - PubMed
    1. Sheng T, Luo B, Zhang W, Ge X, Yu J, Zhang Y, et al. Microneedle-mediated vaccination: innovation and translation. Adv Drug Deliv Rev. 2021;179:113919. https://doi.org/10.1016/j.addr.2021.113919 . - DOI - PubMed

LinkOut - more resources